| Publicaties |
Lokhorst H, van der Heul C, Roerdink H, de Weerdt O. An Observational Post Authorization Study on the Use of Bortezomib in Multiple Myeloma Patients in the Netherlands: Results of An Interim Analysis. Blood 2008; 112(ASH Annual Meeting Abstracts):5200.
Lokhorst HM, Schmidt-Wolf I, Sonneveld P, van der Holt B, Martin H, Barge R, Bertsch U, Schlenzka J, Bos GM, Croockewit S, Zweegman S, Breitkreuz I, Joosten P, Scheid C, van Marwijk-Kooy M, Salwender HJ, van Oers MH, Schaafsma R, Naumann R, Sinnige H, Blau I, Verhoef G, de Weerdt O, Wijermans P, Wittebol S, Duersen U, Vellenga E, Goldschmidt H, Dutch-Belgian,H.O.V.O., German GMMG. Thalidomide in induction treatment increases the very good partial response rate before and after high-dose therapy in previously untreated multiple myeloma. Haematologica 2008; 93(1):124-127.
Meerveld-Eggink A, de Weerdt O, Rijkers GT, van Velzen-Blad H, Biesma DH. Vaccination coverage and awareness of infectious risks in patients with an absent or dysfunctional spleen in the Netherlands. Vaccine 2008; 26(52):6975-6979.
Sluman MA, de Weerdt O, ten Berg JM. Amyloidosis mimicking hypertrophic obstructive cardiomyopathy. 20e Internistendagen Abstractboek (Abstracts submitted to the Annual Meeting of the Netherlands Association of InternalMedicine, 23-25 April 2008, Maastricht, the Netherlands) 2008;77-78.
van Vulpen LFP, Koene HR, de Weerdt O. A complicated course in the treatment of ATLL in an HTLV-1 positive woman from the Dominican Republic. 20e Internistendagen Abstractboek (Abstracts submitted to the Annual Meeting of the Netherlands Association of InternalMedicine, 23-25 April 2008, Maastricht, the Netherlands) 2008;73.
Sluman MA, de Weerdt O, Tersmette M, Biesma DH. A rare fulminant infection in a patient with acute leukemia. 19e Internistendagen Abstractboek (Abstracts submitted to the Annual Meeting of the Netherlands Society of Internal Medicine, Maastricht, the Netherlands) 2007;69-70.
Tenthof van Noorden J, den Ouden H, Stolk MFJ, de Weerdt O, de Bruin PC. Imaging modalities in EATL. In: Mulder CJJ, editor. Atlas of double balloon endoscopy. Medconnect, 2007.
van Binsbergen E, de Weerdt O, Buijs A. A new subtype of MLL-SEPT2 fusion transcript in therapy-related acute myeloid leukemia with t(2;11)(q37;q23): a case report and literature review. Cancer Genetics & Cytogenetics 2007; 176(1):72-75.
Verrij EA, Wassink AMJ, Deneer VHM, de Weerdt O, Geers ABM. Treatment of metformin-induced lactic acidosis. Netherlands Journal of Critical Care 2007; 11(6):305-307.
Wolzak H, Biesma DH, de Weerdt O, Meinders AJ. Spontaneous rupture of the spleen in a patient with chronic myelomonocytic leukemia. 19e Internistendagen Abstractboek (Abstracts submitted to the Annual Meeting of the Netherlands Society of Internal Medicine, Maastricht, the Netherlands) 2007;70-71.
Endeman H, de Weerdt O, Biesma DH. Two mechanisms of carbamazepine induced pancy-topenia within one patient. 18e Internistendagen Abstractboek 2006;67.
Heemstra HE, Wiltink EH, de Weerdt O. Defibrotide belooft het meest. Medicamenteuze behandeling van veno-occlusive disease van de lever. Pharmaceutisch Weekblad 2006; 141(3):103-105.
van der Spek E, Bloem AC, van de Donk NW, Bogers LH, van der Griend R, Kramer MH, de Weerdt O, Wittebol S, Lokhorst HM. Dose-finding study of high-dose simvastatin combined with standard chemotherapy in patients with relapsed or refractory myeloma or lymphoma. Haematologica 2006; 91(4):542-545.
van der Spek E, Bloem A, van de Donk NJCM, van der Griend R, Wittebol S, de Weerdt O, Kramer MHH, Lokhorst HM. Phase I study of simvastatin combined with chemotherapy in patients with relapsed or refractory myeloma and lymphoma. 18e Internistendagen Abstractboek 2006;24-25.
Verrij EA, de Weerdt O, Geers ABM, Wassink AMJ. Treatment of a metformin induced lactic acidosis. 18e Internistendagen Abstractboek 2006;60.
Biesma DH, Bos WJW, de Weerdt O, van Vliet A. Andere maatvoering : maatschappen moeten anticiperen op arbeidswensen van jonge specialisten. Medisch Contact 2005; 60(4):152-154.
Luderer R, Kok M, Niesters HG, Schuurman R, de Weerdt O, Thijsen SF. Real-Time Epstein-Barr Virus PCR for the Diagnosis of Primary EBV Infections and EBV Reactivation. Molecular Diagnosis 2005; 9(4):195-200.
van de Donk NW, de Weerdt O, Veth G, Eurelings M, van Stralen E, Frankel SR, Hagenbeek A, Bloem AC, Lokhorst HM. G3139, a Bcl-2 antisense oligodeoxynucleotide, induces clinical responses in VAD refractory myeloma. Leukemia 2004; 18(6):1078-1084.
de Weerdt O, van de Donk NW, Veth G, Bloem AC, Hagenbeek A, Lokhorst HM. Continuous low-dose cyclophosphamide-prednisone is effective and well tolerated in patients with advanced multiple myeloma. Netherlands Journal of Medicine 2001; 59(2):50-56. |